Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Other
Proparacaine is a rapid-acting ester-type local anesthetic used exclusively for ophthalmic (eye) procedures. It works by blocking sodium channels to provide temporary numbing of the cornea and conjunctiva.
Name
Proparacaine
Raw Name
PROPARACAINE HYDROCHLORIDE
Category
Other
Salt Form
Hydrochloride
Drug Count
3
Variant Count
14
Last Verified
February 17, 2026
RxCUI
1191013, 1191026, 1247445
UNII
U96OL57GOY, 93X55PE38X
About Proparacaine
Proparacaine is a rapid-acting ester-type local anesthetic used exclusively for ophthalmic (eye) procedures. It works by blocking sodium channels to provide temporary numbing of the cornea and conjunctiva.
Detailed information about Proparacaine
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Proparacaine.
According to the FDA-approved labeling, proparacaine was first introduced to provide clinicians with a tool that offers rapid onset and minimal initial irritation. In clinical practice, it is the 'gold standard' for short-term ocular numbing. It is primarily utilized by ophthalmologists and optometrists during diagnostic and surgical procedures that involve contact with the sensitive corneal surface. Because the cornea is one of the most densely innervated tissues in the human body, any contact—even for diagnostic purposes—can be extremely painful without the intervention of an agent like proparacaine.
Proparacaine works by stabilizing the neuronal membrane. At the molecular level, it inhibits the ionic fluxes required for the initiation and conduction of nerve impulses. Specifically, proparacaine molecules bind to the internal portion of voltage-gated sodium channels located within the nerve cell membranes. By binding to these channels, the drug prevents the large transient increase in the permeability of the membrane to sodium ions that is normally produced by a slight depolarization.
When sodium cannot enter the nerve cell, the action potential (the electrical signal of pain) cannot be generated or propagated along the nerve fiber. This results in a localized 'nerve block' on the surface of the eye. For the patient, this translates to a complete loss of sensation in the cornea and conjunctiva, allowing the physician to perform procedures without the patient feeling pain or the urge to blink (the corneal reflex). The onset of action is remarkably fast, typically occurring within 20 seconds of administration, and the effects generally last for approximately 15 to 20 minutes.
Proparacaine is FDA-approved for several clinical indications where brief local anesthesia of the eye is required:
Proparacaine is available almost exclusively as an ophthalmic solution (eye drops). The most common concentration is 0.5% proparacaine hydrochloride. It is often supplied in 15 mL plastic dropper bottles. Some formulations are preservative-free (single-use), while others contain benzalkonium chloride as a preservative. It is important to note that the solution should be clear and colorless; if the solution turns amber or dark brown, it has oxidized and should be discarded.
> Important: Only your healthcare provider can determine if Proparacaine is right for your specific condition. It is never intended for self-administration or home use.
Proparacaine dosage is determined strictly by the nature of the procedure being performed. Because it is a professional-use-only medication, a healthcare provider will administer the drops in a clinical setting.
It is critical to note that the cumulative effect of multiple drops increases the risk of corneal toxicity. Therefore, the minimum number of drops required to achieve the necessary anesthesia is always preferred.
Proparacaine is frequently used in pediatric ophthalmology for diagnostic exams and minor procedures. The dosage for children is generally the same as for adults (1 to 2 drops), as the surface area of the eye does not vary as significantly as body weight. However, safety and effectiveness in very young infants have not been established through large-scale clinical trials, though it is commonly used 'off-label' in neonatal intensive care units for retinopathy of prematurity (ROP) screenings under strict medical supervision.
Because proparacaine is used topically and in very small amounts, systemic levels are usually negligible. Consequently, no specific dosage adjustments are required for patients with kidney disease. However, clinicians should exercise caution in patients with known severe renal failure if multiple doses are administered.
Unlike amide anesthetics, which are metabolized by the liver, proparacaine is primarily broken down by plasma enzymes. Therefore, hepatic impairment does not typically necessitate a change in the ophthalmic dosage.
No specific dosage adjustments are recommended for the elderly. However, older patients may have thinner corneal epithelium or reduced tear production (dry eye), which can make the cornea more susceptible to the toxic effects of repeated anesthetic use. Clinicians should monitor for delayed corneal healing in this population.
Proparacaine is administered by a trained medical professional. The process typically involves:
Storage Conditions: Proparacaine should ideally be stored in a refrigerator (2°C to 8°C or 36°F to 46°F) to prevent oxidation. It must be protected from light. If a bottle is kept at room temperature for an extended period, it may turn brown, indicating it is no longer safe to use.
Since proparacaine is administered only as needed for specific medical procedures by a healthcare professional, there is no 'missed dose' schedule for patients to follow. If a procedure is delayed and the numbing effect wears off, the doctor will simply instill another drop.
An 'overdose' of proparacaine in the eye usually manifests as local tissue toxicity. Signs include severe redness, swelling of the eyelids, and a 'cloudy' appearance of the cornea (keratopathy). Systemic overdose is extremely rare but could theoretically cause central nervous system (CNS) stimulation followed by depression (seizures, followed by respiratory distress). In the event of accidental ingestion, the patient should seek emergency medical care immediately.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or attempt to use this medication without medical guidance.
The most frequent side effect of proparacaine is an immediate, transient stinging or burning sensation upon instillation. This typically lasts for 5 to 30 seconds and is a result of the pH of the solution and the chemical nature of the anesthetic. Other common effects include:
Some patients may experience more pronounced local reactions, including:
While rare when used correctly in a clinical setting, proparacaine can cause severe ocular damage if misused.
> Warning: Stop using Proparacaine and contact your doctor immediately if you experience any of these serious symptoms:
Proparacaine is strictly contraindicated for long-term or chronic use. Prolonged use (even over a few days) can lead to 'corneal melting' or necrotizing keratitis. This is a devastating condition where the corneal tissue breaks down and thins, potentially leading to corneal perforation and permanent blindness. Chronic use also delays the natural healing process of the eye and can mask the symptoms of a worsening infection or injury. Because proparacaine eliminates the blink reflex, the eye is also susceptible to drying out and accidental trauma (scratches) that the patient cannot feel.
There are currently no FDA Black Box Warnings for Proparacaine Hydrochloride. However, the professional labeling carries a 'Precautions' section that is treated with the same level of clinical gravity as a black box warning: it explicitly states that proparacaine should never be prescribed for patient self-administration due to the risk of irreversible corneal damage.
Report any unusual symptoms to your healthcare provider. If you feel that your eye is not returning to normal sensation within an hour, or if pain develops later, consult your ophthalmologist immediately.
Proparacaine is a powerful medical tool that must be handled with extreme care. The most critical safety point is that it is for professional use only. It should never be given to a patient to take home for pain relief. Patients who use proparacaine at home for conditions like 'welder's flash' or corneal abrasions are at high risk for permanent eye damage. Because the eye is numb, the patient loses the protective blink reflex, which normally clears debris and keeps the eye lubricated. Without this reflex, the cornea can dry out, become infected, or be severely scratched without the patient realizing it until the damage is extensive.
No FDA black box warnings for Proparacaine. However, the standard of care dictates that the risk of corneal melting from inappropriate use is the primary safety concern for this medication.
No routine lab tests (like blood counts or liver function tests) are required for the use of proparacaine. However, clinical monitoring by the healthcare provider is essential:
Patients should be advised not to drive or operate machinery until the effects of the anesthetic have completely worn off and their vision is clear. Because proparacaine can cause temporary blurring and a loss of protective reflexes, it is unsafe to perform tasks requiring precise vision and environmental awareness while the eye is numb.
There are no known direct interactions between topical proparacaine and alcohol. However, alcohol can impair judgment and coordination. Since a patient with a numb eye must be extremely careful not to rub or touch the eye, alcohol consumption could increase the risk of accidental ocular injury during the recovery period.
Proparacaine is used for one-time or short-term procedures; therefore, there is no withdrawal syndrome or need for tapering. Once the procedure is complete, the medication is simply not used again. The numbing effect will naturally dissipate within 20 minutes.
> Important: Discuss all your medical conditions and any history of eye problems with your healthcare provider before any procedure involving Proparacaine.
There are no absolute drug-drug contraindications that would prevent a single diagnostic dose of proparacaine. However, it should not be used concurrently with other topical anesthetics, as this significantly increases the risk of corneal epithelial toxicity and 'melting.'
There are no known interactions between proparacaine and specific foods, including grapefruit, dairy, or high-fat meals. Because the drug is applied topically to the eye and has minimal systemic absorption, dietary factors do not influence its efficacy or safety profile.
There are no documented interactions with common herbal supplements like St. John's Wort or Ginkgo Biloba. However, patients should always disclose their full supplement list to their doctor, as some herbs can affect bleeding risk or overall ocular health.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially other eye drops.
Proparacaine must NEVER be used in the following circumstances:
Healthcare providers will perform a risk-benefit analysis in these situations:
Proparacaine is an ester. There is a high degree of cross-sensitivity among the ester group of local anesthetics. If you have reacted poorly to 'Novocain' (procaine) at the dentist, you must inform your eye doctor. There is generally no cross-sensitivity between proparacaine and the 'amide' group (like lidocaine or bupivacaine).
> Important: Your healthcare provider will evaluate your complete medical history and any known allergies before prescribing or administering Proparacaine.
FDA Pregnancy Category C. Animal reproduction studies have not been conducted with proparacaine. It is also not known whether proparacaine can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Because systemic absorption of a single ophthalmic drop is extremely low, the risk to the fetus is generally considered to be minimal. However, proparacaine should be used during pregnancy only if clearly needed and if the potential benefit justifies the potential risk to the fetus. Healthcare providers often apply pressure to the tear duct (nasolacrimal occlusion) after instillation to further reduce any systemic absorption in pregnant patients.
It is not known whether proparacaine is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when proparacaine is administered to a nursing woman. However, given the tiny dose and short half-life, it is unlikely that a significant amount would reach the infant through breast milk. As a precaution, nursing mothers can also use nasolacrimal occlusion for 1-2 minutes after the drop is instilled.
Proparacaine is considered safe and effective for use in children when administered by a professional. It is frequently used for eye exams in infants and children. The main concern in the pediatric population is the risk of the child rubbing their eye while it is numb, which can cause a corneal abrasion. Parents must be instructed to monitor their child closely until the anesthesia wears off.
No overall differences in safety or effectiveness have been observed between elderly and younger patients. However, the elderly may have a higher prevalence of dry eye syndrome or corneal endothelial changes. These conditions may slightly increase the sensitivity of the ocular surface to the toxic effects of anesthetics. Careful monitoring of the corneal surface post-procedure is advised.
No dosage adjustments are necessary for patients with renal impairment. The total dose used in ophthalmic procedures (typically 0.5 mg to 1 mg) is far below the threshold that would require renal clearance of systemic metabolites to prevent toxicity.
No dosage adjustments are necessary for patients with hepatic impairment. The primary metabolic pathway is via plasma enzymes, not the liver.
> Important: Special populations require individualized medical assessment by a qualified specialist.
Proparacaine acts as a local anesthetic by reversibly blocking nerve conduction. It penetrates the nerve sheath and binds to specific receptor sites on the voltage-gated sodium channels within the neuronal membrane. This binding stabilizes the membrane in a polarized state, preventing the rapid influx of sodium ions that is required for the depolarization of the nerve. Without depolarization, the action potential cannot be triggered, and the 'pain signal' never reaches the brain. Its specific action on the sensory nerves of the cornea makes it an ideal agent for ocular surface anesthesia.
The onset of anesthesia is nearly instantaneous, usually beginning within 20 seconds of the drop hitting the eye. The depth of anesthesia is sufficient for procedures involving contact with the cornea. The duration of action is relatively short, typically 15 to 20 minutes. If the drug is applied repeatedly, the duration can be slightly extended, but this also increases the risk of epithelial toxicity. There is no significant effect on pupil size (mydriasis) or the eye's ability to focus (cycloplegia).
| Parameter | Value |
|---|---|
| Bioavailability | Minimal (Topical) |
| Onset of Action | 20 seconds |
| Duration of Effect | 15-20 minutes |
| Protein Binding | Not clinically significant |
| Metabolism | Plasma Pseudocholinesterases |
| Excretion | Renal (Metabolites) |
Proparacaine is classified as a local anesthetic of the ester type. It is specifically a meta-aminobenzoic acid ester. It is related to other local anesthetics like tetracaine and benoxinate, which are also used in ophthalmology, but it is chemically distinct from the amide-type anesthetics like lidocaine or bupivacaine.
Medications containing this ingredient
Common questions about Proparacaine
Proparacaine is a fast-acting numbing medication used exclusively for the eye. Healthcare providers use it to perform painless eye exams, such as measuring eye pressure (tonometry) or looking at the drainage angle of the eye. It is also used to numb the eye before removing foreign objects, like a piece of dust or metal, or before removing surgical stitches. Because it works within seconds, it allows doctors to perform these sensitive procedures without causing the patient discomfort or triggering the urge to blink. It is only used in a clinical setting and is never prescribed for home use.
The most common side effect is a brief stinging or burning sensation that occurs immediately after the drop is placed in the eye. This usually lasts only a few seconds. You may also notice some temporary redness of the eye or slight blurring of your vision for a few minutes. Some patients might feel like there is something in their eye as the medication wears off. These effects are generally mild and resolve quickly on their own. However, if you experience severe pain or your vision does not clear up, you should notify your doctor immediately.
There is no known direct chemical interaction between proparacaine eye drops and alcohol. However, because proparacaine numbs your eye, you lose the ability to feel if your eye is being scratched or injured. Alcohol can impair your coordination and judgment, which might make you more likely to accidentally rub or poke your eye while it is still numb. To ensure your safety, it is best to avoid alcohol until the numbing effect has completely worn off and your protective blink reflex has returned. Always follow the specific recovery instructions provided by your ophthalmologist.
Proparacaine is classified as FDA Pregnancy Category C, meaning there haven't been enough controlled studies in humans to rule out all risks. However, because only a tiny amount of the drug is used topically in the eye, very little of it reaches the bloodstream. Most doctors consider a single use for a necessary eye exam to be low risk. If you are pregnant, your doctor may use a technique called nasolacrimal occlusion (pressing on the corner of the eye) to further reduce any absorption. Always inform your eye doctor if you are pregnant or planning to become pregnant before any procedure.
Proparacaine is one of the fastest-acting anesthetics available for the eye. It typically begins to numb the surface of the eye within 20 seconds of administration. This rapid onset is one of the reasons it is so widely used for quick diagnostic tests. The full numbing effect usually lasts for about 15 to 20 minutes, which is long enough for most minor procedures or exams. If a procedure takes longer, the doctor may add another drop to maintain the effect. You will know it is working because you will lose the sensation of your eyelids touching your eye.
Proparacaine is not a medication that you take on a regular schedule; it is a one-time use drug administered by a doctor for a specific procedure. Therefore, there is no 'stopping' the medication or risk of withdrawal. Once the doctor applies the drops and performs the exam, the medication's effect wears off naturally within 20 minutes. You do not need to do anything special to discontinue its use. It is important to remember that you should never attempt to use this medication on your own or obtain it outside of a medical facility.
Since proparacaine is only administered by healthcare professionals during an office visit or surgery, it is impossible for a patient to 'miss a dose' in the traditional sense. The medication is not used for daily treatment at home. If you are undergoing a procedure and the doctor feels the anesthesia is wearing off too soon, they will simply administer another drop. You do not have any responsibility for the timing or dosing of this medication; your healthcare provider manages the entire process during your appointment.
No, proparacaine does not cause weight gain. It is a local anesthetic applied only to the surface of the eye for a very short period. Because the drug is used in such small quantities and acts locally rather than systemically, it does not affect your metabolism, appetite, or body weight. Any weight changes you experience would be unrelated to the use of proparacaine eye drops. If you have concerns about weight changes, you should discuss them with your primary care physician to identify other potential causes.
Proparacaine can generally be used even if you are taking other systemic medications (pills). However, it can interact with other eye drops. For example, it may interfere with the action of sulfonamide (sulfa) eye drops used for infections. It can also increase the absorption of other eye medications by slightly changing the surface of the eye. You must tell your eye doctor about all the eye drops, vitamins, and oral medications you are currently using. Your doctor will coordinate the timing of the drops to ensure they are all safe and effective.
Yes, proparacaine hydrochloride 0.5% is available as a generic ophthalmic solution. It has been available for many years and is produced by several different pharmaceutical manufacturers. Generic versions are required by the FDA to have the same active ingredient, strength, and effectiveness as the brand-name versions like Alcaine or Ophthaine. Whether your doctor uses a brand-name or a generic version, the clinical effect and the safety precautions remain exactly the same. It is a standard tool found in almost every eye care professional's office.